An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, Johns Hopkins ...

The researchers identified the structure of this machine, the mitochondrial pyruvate carrier (MPC), and 50 years since its discovery, have shown how it operates like the lock on a canal to transport ...

Another reason for choosing a particular modality is that it is a team’s specialty. Strategic choices can be less about determining which modality best fits a potential target than about choosing a ...

A new, neuroplasticity-promoting drug closely related to LSD harnesses the psychedelic’s therapeutic power with reduced ...

A team at UC Davis has created a new drug called JRT that mimics LSD’s brain-healing effects without the hallucinogenic side ...

In a major step toward more reliable AI-assisted molecular design, researchers from National Taiwan University have ...

Psychedelics drugs with the hallucinatory effects shut down show promise in reconnecting broken neural synaptic connections, which are the cause of some grave diseases.

Researchers have developed a new, neuroplasticity-promoting drug closely related to LSD that harnesses the psychedelic's therapeutic power with reduced hallucinogenic potential.

Researchers have discovered a type of "molecular glue" that can be used to inhibit certain pathological protein interactions.

Financial Results About Applied Therapeutics Applied Therapeutics is a clinical-stage biopharmaceutical company committed to the development of novel drug candidates against validated molecular ...

CRIS Cancer Foundation and the ICR are offering 2-3 year fellowships to support the development of outstanding early ...

The discovery could help create new "sensorially appealing foods" that improve digestion and feelings of fullness.